With generative AI rapidly advancing the transformation of smart healthcare, Allen Lien, Chairman of Acer Medical, notes that the business models for AI medical devices have shifted from predictive AI to “demand-driven” solutions. These include AI-assisted diagnostics and AI service platforms integrated into clinical settings, leveraging generative AI. By understanding customer needs even before product launch, Acer Medical gains early market traction and strengthens future operational momentum.

Lien stated that Taiwan’s Software as a Medical Device (SaMD) market experienced rapid growth between 2023 and 2025. Medical institutions have reached a consensus on the necessity of AI adoption and are willing to allocate additional resources, with Acer Medical acting as a collaborative partner to drive this growth.

He further pointed out that the domestic shortage of healthcare personnel continues to worsen. When small- and medium-sized medical institutions recruit new staff, candidates prioritize whether the hospital has implemented AI to assist with medical records and administrative processes rather than salary. This situation exacerbates concerns that larger hospitals or medical schools with more resources will attract talent away, intensifying manpower challenges. These operational pain points make demand-driven product development a promising direction for Acer Medical. Lien emphasized that this approach—developing products based on actual demand rather than creating a product first and then seeking customers—yields greater effectiveness in business expansion.

Lien also observed that over the past three years, Taiwan’s medical software device market has grown rapidly. This trend indicates that hospital leadership recognizes the value of integrating generative AI into healthcare systems, providing Acer Medical with new opportunities to accelerate mutual growth with the medical industry.

Resource: 需求驅動產品 宏碁智醫新契機